GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor – The GRI Opportunity Spotlight Event
24 juil. 2023 09h00 HE
|
GRI Bio, Inc.
- Live moderated webcast with members of the GRI Bio management team on Thursday, July 27th at 1:00 PM ET LA JOLLA, CA, July 24, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio”...
Bispecific Antibody Market revenue to cross USD 1 Billion by 2035, says Research Nester
24 juil. 2023 07h00 HE
|
Research Nester
New York, July 24, 2023 (GLOBE NEWSWIRE) -- The global bispecific antibody market size is slated to expand at ~7% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 1...
TolerogenixX expands Phase II immune-tolerance trial and closes EUR 12 million Series A financing
06 juil. 2023 04h00 HE
|
AKAMPION
Ongoing Phase IIb study expands to arm B5-year results of phase I study confirm efficacy and safety of novel immune-tolerance inducing cell therapy in organ transplantationSecond closing of Series A...
Photopheresis Products Market to exceed USD 488 billion by 2032, says Global Market Insights Inc.
27 juin 2023 07h00 HE
|
Global Market Insights Inc.
Selbyville, Delaware, June 27, 2023 (GLOBE NEWSWIRE) -- Photopheresis Products Market size is predicted to surpass USD 488 billion by 2032. Advancements in medical technology and increasing demand...
Autoinjectors Market to Grow at 16.2% CAGR and Reach USD 3.8 Bn by 2031 | Excusive Research by Transparency Market Research
15 juin 2023 10h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 15, 2023 (GLOBE NEWSWIRE) -- The global autoinjectors market was valued at USD 1.0 Bn in 2022 and is projected to grow at a CAGR of 16.2% from 2023 to 2031....
Lyophilized Injectable Market Primed to Surpass USD 5 Billion by 2031, According to Transparency Market Research
05 juin 2023 06h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 05, 2023 (GLOBE NEWSWIRE) -- The global lyophilized injectable market is projected to exceed value of US$ 5 Bn by 2031. It is expected to expand at a CAGR...
selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis
30 mai 2023 04h00 HE
|
AKAMPION
Ongoing phase 1b trial is designed to evaluate safety, tolerability, and efficacy of si-544 in T-cell mediated autoimmunity Dosing of MAD stage has been initiated; first results expected for late...
ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002
24 mai 2023 04h00 HE
|
AKAMPION
- First-in-class checkpoint inhibitor IOS-1002 (targeting LILRB1 (ILT2), LILRB2 (ILT4), KIR3DL1) being evaluated as mono and combination therapy in patients with advanced solid tumors Schlieren...
Monoclonal Antibodies Market Size & Share to Surpass $155.2 Billion by 2028 | Vantage Market Research
10 avr. 2023 05h10 HE
|
Vantage Market Research
WASHINGTON, April 10, 2023 (GLOBE NEWSWIRE) -- The Global Monoclonal Antibodies Market is valued at USD 111.93 Billion in 2022 and is projected to reach a value of USD 186.67 Billion by 2030 at a...
BiondVax to Present at BIO-Europe Spring
16 mars 2023 13h10 HE
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing...